Imagine you're battling advanced biliary tract cancer (ABTC), and your doctors suggest a mix of drugs: nivolumab, modified gemcitabine, and S-1. This combo showed promise in a past trial, but PD-L1 levels didn't tell us much about how well it would work. So, scientists looked at another marker, LAG-
You might not think about it, but the time of day you get your cancer treatment could make a difference. Scientists have been looking into how our body's internal clock, called the circadian rhythm, affects how well cancer drugs work. One type of drug, called immune checkpoint inhibitors (ICIs), has
Immune treatments, or immune checkpoint inhibitors (ICIs), are game-changers for some people with far-advanced solid tumors. But when it comes to biliary tract cancer (BTC), doctors are still figuring out who gets the most benefit from these treatments. A recent trial focused on pembrolizumab, an IC
Biliary tract cancers, like cholangiocarcinoma and gallbladder cancer, are growing more common worldwide, and most patients get diagnosed when the disease has already advanced, leading to a grim outlook. Recently, combining immune checkpoint inhibitors, such as durvalumab and pembrolizumab, with the
China Dongxiang (Group) Co (HK:3818) has some news for its shareholders. The company is planning to take back unclaimed dividends that date back to 2013. If you're a shareholder, you have until January 14, 2025, to claim what’s yours. In other developments, the company has added a new face to its le
In a recent development, China has deployed one of the world's largest coast guard ships to Scarborough Shoal, a reef in the South China Sea that is claimed by both China and the Philippines. This massive vessel, nicknamed the "monster ship, " is over 12, 000 tons and 541 feet long. It's equipped wi
Immune-checkpoint inhibitors (ICIs) have emerged as a powerful tool in the fight against advanced squamous cell lung cancer (LUSC). These drugs offer a glimmer of hope for patients who haven't found success with other treatments. But it's not a one-size-fits-all solution—some patients don't respond
Ever noticed how people with early breast cancer often get quicker treatments? That's what scientists already know. But what about those with metastatic breast cancer (MBC), where it spreads to other parts of the body? Not much is known about why they face delays in getting care. This study is chang
Imagine a time when the world was much colder and humans were just starting to roam the earth. In a remote cave in Utah, a team of scientists and cavers found something extraordinary: a nearly complete skeleton of a red fox. This isn't just any fox; it's one that lived over 26, 000 years ago, during
This year's CES event in Las Vegas is all about artificial intelligence (AI). Companies are showcasing AI-enabled gadgets like smart refrigerators and AI agents. Nvidia and Microsoft are among the big names participating. Investors are now focusing on the return on investment (ROI) for AI firms, wit
